As Covid-19 continues to exacerbate a nationwide healthcare worker shortage, health systems are experimenting with different ways to maximize stretched human resources, including technological solutions. One company that works with health systems believes that AI could help alleviate current labor woes. John Frownfelter, CEO of the Suwanee, Georgia-based artificial intelligence company Jvion said AI can actually improve efficiency in how medicine is practiced. Linked to the Jvion site below to avoid linking "out" up high.] AI has been heavily hyped for years but now, amid the pandemic, achieving operating efficiencies has taken on a new urgency at cash-strapped and short-staffed hospitals.

AI in healthcare has a bias problem. Last year, it came to light that six algorithms used on an estimated 60-100 million patients nationwide were prioritizing care coordination for white patients over black patients for the same level of illness.The reason? The algorithm was trained on costs in insurance claims data, predicting which patients would be expensive in the future based on who was expensive in the past. Historically, less is spent on black patients than white patients, so the algorithm ended up perpetuating existing bias in healthcare.Therein lies the danger of using narrow datasets in Artificial Intelligence: If the data is biased, the AI will be biased. That doesn't mean we should (or, now that the genie is out of the bottle, can) abandon AI.

Can broader datasets help developers avoid accidentally perpetuating deep-rooted biases in vital institutions like healthcare and education? AI in healthcare has a bias problem. Last year, it came to light that six algorithms used on an estimated 60-100 million patients nationwide were prioritizing care coordination for white patients over black patients for the same level of illness. The algorithm was trained on costs in insurance claims data, predicting which patients would be expensive in the future based on who was expensive in the past. Historically, less is spent on black patients than white patients, so the algorithm ended up perpetuating existing bias in healthcare.

The daily email that arrived in physician Samantha Wang's inbox at 8 a.m., just before morning rounds, contained a list of names and a warning: These patients are at high risk of dying within the next year. One name that turned up again and again belonged to a man in his 40s, who had been admitted to Stanford University's hospital the previous month with a serious viral respiratory infection. He was still much too ill to go home, but Wang was a bit surprised that the email had flagged him among her patients least likely to be alive in a year's time. This list of names was generated by a machine, an algorithm that had reached its conclusions by scanning the patients' medical records. The email was meant as something of a nudge, to encourage Wang to broach a delicate conversation with her patient about his goals, values, and wishes for his care should his condition worsen.

As the novel coronavirus (COVID-19) continues to spread across the world, governments and hospitals are being overwhelmed with an influx of patients. Under such circumstances, one of the key challenges they must address is managing their resources and developing care and hospitalization strategies that can prioritize the riskiest patients. This is one area where artificial intelligence can help, experts at Jvion believe. The company, which specializes in clinical AI, is undertaking a data analysis project that will inform COVID-19 readiness strategies and help hospitals take a proactive approach to manage patient populations in the inpatient and outpatient settings. Jvion is using machine learning algorithms to determine the social risk factors that make people more likely to contract and spread the virus or acquire an infection that requires hospitalization.

This article is part of our ongoing coverage of the fight against coronavirus. As the novel coronavirus (COVID-19) continues to spread across the world, governments and hospitals are being overwhelmed with an influx of patients. Under such circumstances, one of the key challenges they must address is managing their resources and developing care and hospitalization strategies that can prioritize the riskiest patients. This is one area where artificial intelligence can help, experts at Jvion believe. The company, which specializes in clinical AI, is undertaking a data analysis project that will inform COVID-19 readiness strategies and help hospitals take a proactive approach to manage patient populations in the inpatient and outpatient settings.

This article is part of our ongoing coverage of the fight against coronavirus. As the novel coronavirus (COVID-19) continues to spread across the world, governments and hospitals are being overwhelmed with an influx of patients. Under such circumstances, one of the key challenges they must address is managing their resources and developing care and hospitalization strategies that can prioritize the riskiest patients. This is one area where artificial intelligence can help, experts at Jvion believe. The company, which specializes in clinical AI, is undertaking a data analysis project that will inform COVID-19 readiness strategies and help hospitals take a proactive approach to manage patient populations in the inpatient and outpatient settings.

PHOENIX--Early adopters of artificial intelligence solutions are beginning to see success in clinical areas such as predicting readmissions and avoidable emergency department visits, according to a joint report from KLAS Research and the College of Healthcare Information Management Executives (CHIME). KLAS and CHIME polled early adopter healthcare organizations using AI software, specifically machine learning and natural language processing, to evaluate the gains they've achieved in clinical, financial and operational areas. "The most exciting insight from our research is that artificial intelligence (machine learning and natural language processing) has truly begun to make a difference in healthcare. It's not all just smoke," Ryan Pretnik, director of research and strategy at KLAS and co-author of the study, said via email. "Artificial intelligence is driving outcomes, saving patient lives, and driving operational and financial efficiencies for providers and payers."

Sepsis is a major medical issue. In the next week, an estimated 5,000 people will die from sepsis in the U.S. alone, and one third of all hospital deaths are related to sepsis (according to U.S. Centers for Disease Control and Prevention figures). These deaths are preventable, but by the time sepsis is detected, it's often already too late. One way to reduce incidences of sepsis is with the application of artificial intelligence. The staff at Sentara Healthcare are using an AI-enabled prescriptive analytic tool developed by Jvion, which identifies who is at risk of sepsis, alerts clinicians and suggests interventions tailored to each patient's needs.

Machine Learning (ML) provides methods, techniques, and tools that can help solving diagnostic and prognostic problems in a variety of medical domains. The rising technology in Machine Learning in Medicine market is also depicted in this research report. Factors that are boosting the growth of the market, and giving a positive push to thrive in the global market is explained in detail. The report delivers a comprehensive overview of the crucial elements of the market and elements such as drivers, restraints, current trends of the past and present times, supervisory scenario, and technological growth. A thorough analysis of these elements has been accepted for defining the future growth prospects of the global Machine Learning in Medicine market.